Article
A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblasts
2022-09-28
Abstract excerpt
<h4>ABSTRACT</h4> A major challenge for understanding and treating Amyotrophic Lateral Sclerosis (ALS) is that most patients have no known genetic cause. Even within defined genetic subtypes, patients display considerable clinical heterogeneity. It is unclear how to identify subsets of ALS patients that share common molecular dysregulation or could respond similarly to treatment. Here, we developed a scalable mic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fc786e71-02a1-5b9e-848d-0f41d89e2930
- DOI
- 10.1101/2022.09.27.509770
